US20030104509A1 - Device and method for the determination of protein domain boundaries - Google Patents
Device and method for the determination of protein domain boundaries Download PDFInfo
- Publication number
- US20030104509A1 US20030104509A1 US10/234,024 US23402402A US2003104509A1 US 20030104509 A1 US20030104509 A1 US 20030104509A1 US 23402402 A US23402402 A US 23402402A US 2003104509 A1 US2003104509 A1 US 2003104509A1
- Authority
- US
- United States
- Prior art keywords
- protease
- protein
- concentration
- axis
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 72
- 108020001580 protein domains Proteins 0.000 title abstract description 8
- 239000004365 Protease Substances 0.000 claims abstract description 163
- 102000035195 Peptidases Human genes 0.000 claims abstract description 152
- 108091005804 Peptidases Proteins 0.000 claims abstract description 152
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 115
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 115
- 230000029087 digestion Effects 0.000 claims abstract description 25
- 239000011159 matrix material Substances 0.000 claims abstract description 19
- 230000002797 proteolythic effect Effects 0.000 claims abstract description 9
- 230000015556 catabolic process Effects 0.000 claims abstract description 8
- 238000006731 degradation reaction Methods 0.000 claims abstract description 8
- 235000018102 proteins Nutrition 0.000 claims description 108
- 235000019419 proteases Nutrition 0.000 claims description 101
- 239000012634 fragment Substances 0.000 claims description 47
- -1 poly(acrylic acid) Polymers 0.000 claims description 43
- 108090000317 Chymotrypsin Proteins 0.000 claims description 13
- 229960002376 chymotrypsin Drugs 0.000 claims description 13
- 108090000631 Trypsin Proteins 0.000 claims description 12
- 102000004142 Trypsin Human genes 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 239000012588 trypsin Substances 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 108010067770 Endopeptidase K Proteins 0.000 claims description 10
- 108090000526 Papain Proteins 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 235000019834 papain Nutrition 0.000 claims description 10
- 229940055729 papain Drugs 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000001269 time-of-flight mass spectrometry Methods 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 5
- 229910044991 metal oxide Inorganic materials 0.000 claims description 5
- 150000004706 metal oxides Chemical class 0.000 claims description 5
- 102100022749 Aminopeptidase N Human genes 0.000 claims description 4
- 108010004032 Bromelains Proteins 0.000 claims description 4
- 108010049990 CD13 Antigens Proteins 0.000 claims description 4
- 108090000087 Carboxypeptidase B Proteins 0.000 claims description 4
- 102000003670 Carboxypeptidase B Human genes 0.000 claims description 4
- 108010080937 Carboxypeptidases A Proteins 0.000 claims description 4
- 102000000496 Carboxypeptidases A Human genes 0.000 claims description 4
- 102000005572 Cathepsin A Human genes 0.000 claims description 4
- 108010059081 Cathepsin A Proteins 0.000 claims description 4
- 108090001069 Chymopapain Proteins 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 4
- 108010035532 Collagen Proteins 0.000 claims description 4
- 102000029816 Collagenase Human genes 0.000 claims description 4
- 108060005980 Collagenase Proteins 0.000 claims description 4
- 108010074860 Factor Xa Proteins 0.000 claims description 4
- 108090000270 Ficain Proteins 0.000 claims description 4
- 102000013382 Gelatinases Human genes 0.000 claims description 4
- 108010026132 Gelatinases Proteins 0.000 claims description 4
- 108010051815 Glutamyl endopeptidase Proteins 0.000 claims description 4
- 108060005987 Kallikrein Proteins 0.000 claims description 4
- 102000001399 Kallikrein Human genes 0.000 claims description 4
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 4
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 4
- 102000057297 Pepsin A Human genes 0.000 claims description 4
- 108090000284 Pepsin A Proteins 0.000 claims description 4
- 102000013566 Plasminogen Human genes 0.000 claims description 4
- 108010051456 Plasminogen Proteins 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 4
- 108010059712 Pronase Proteins 0.000 claims description 4
- 101001091368 Rattus norvegicus Glandular kallikrein-7, submandibular/renal Proteins 0.000 claims description 4
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 claims description 4
- 229920005654 Sephadex Polymers 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 108090001109 Thermolysin Proteins 0.000 claims description 4
- 108090000190 Thrombin Proteins 0.000 claims description 4
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 claims description 4
- 239000011543 agarose gel Substances 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 229960002976 chymopapain Drugs 0.000 claims description 4
- 108090001092 clostripain Proteins 0.000 claims description 4
- 229920001436 collagen Polymers 0.000 claims description 4
- 229960002424 collagenase Drugs 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 235000019836 ficin Nutrition 0.000 claims description 4
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 229940111202 pepsin Drugs 0.000 claims description 4
- 229940012957 plasmin Drugs 0.000 claims description 4
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 229920000058 polyacrylate Polymers 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920000193 polymethacrylate Polymers 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 235000019833 protease Nutrition 0.000 claims description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 4
- 108010059339 submandibular proteinase A Proteins 0.000 claims description 4
- 229960004072 thrombin Drugs 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 21
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- 230000017854 proteolysis Effects 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 230000000903 blocking effect Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 229960001322 trypsin Drugs 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 6
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 108010069411 transcription factor S-II Proteins 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000012460 protein solution Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000002424 x-ray crystallography Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- 101100278012 Escherichia coli (strain K12) dnaG gene Proteins 0.000 description 2
- 101100165173 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) basS gene Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 101100421924 Thermus thermophilus (strain ATCC BAA-163 / DSM 7039 / HB27) spo0C gene Proteins 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 102100026428 Transcription elongation factor A protein 2 Human genes 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000002358 autolytic effect Effects 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 101150004979 flmA gene Proteins 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 101150048892 parB gene Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000006226 wash reagent Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000009875 biological transport Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052878 cordierite Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011544 gradient gel Substances 0.000 description 1
- 238000000669 high-field nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910052596 spinel Inorganic materials 0.000 description 1
- 239000011029 spinel Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000018405 transmission of nerve impulse Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000010456 wollastonite Substances 0.000 description 1
- 229910052882 wollastonite Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Definitions
- the present invention generally relates to methods for determination of protein structure and in particular concerns the use of immobilized proteases to identify domain boundaries of proteins, and an apparatus for digesting proteins.
- the molecular structure of proteins allows them play crucial roles in virtually all biological processes, including: enzymatic catalysis, transport and storage; coordinated motion; mechanical support; immune protection; generation and transmission of nerve impulses; and control of growth and differentiation.
- the side chains of the different amino acids that comprise proteins enables these long macromolecules to fold into distinctive structures and form complementary surfaces and clefts and enables them to specifically recognize and interact with highly diverse molecules.
- the catalytic power of enzymes comes from their capacity to bind substrates in precise orientations and to stabilize transition states in the making and breaking of chemical bonds. Conformational changes transmitted between distant sites in protein molecules are at the heart of the capacity of proteins to transduce energy and information.
- the three dimensional structure of a protein is the key to its ability to function in virtually all biological processes.
- Secondary structure refers to the spatial arrangement of amino acid residues that are near one another in the linear sequence. Some of these steric relationships are of a regular kind, giving rise to a periodic structure.
- Tertiary structure refers to the spatial arrangement of amino acid residues that are far apart in the linear sequence, and to the pattern of disulfide bonds.
- quaternary structure refers to proteins containing more than one polypeptide chain where each polypeptide chain is referred to as a subunit, and the quaternary structure refers to the spatial arrangement subunits and the nature of their contacts.
- polypeptide chains fold into two or more compact regions that may be joined by a flexible segment of polypeptide chain.
- These compact globular units, called domains range in size from about 50 to 400 amino acid residues, and they seem to be the modular units from which proteins are constructed. While small proteins may contain only a single domain, larger proteins contain a number of domains, which are often connected by relatively open lengths of polypeptide chain.
- all information required for folding a protein chain is contained in the protein's amino acid sequence, it is not yet known how to “read” this information so as to predict the detailed three-dimensional structure of a protein whose sequence is known.
- the technique of X-ray crystallography utilizes the diffraction of X-rays from crystals in order to determine the precise arrangement of atoms within the crystal.
- the limiting step in the technique involves the growth of a suitable crystalline sample. This requires the growth of reasonably ordered protein crystals (crystals which diffract X-rays to at least 3.0 angstroms resolution or less).
- a strategic approach has been developed to identify protein domains that are amenable to NMR analysis or X-ray crystallography.
- Different domains of a protein may be linked together by intervening sections of polypeptide chain to form the protein molecule. Analysis of a single domain is more easily conducted in isolation from its parent protein. The determination of an individual domain structure facilitates elucidation of the parent structure.
- Limited proteolysis has been used to isolate and identify stable domains of proteins, which have a high likelihood of being good targets for protein structure determination. The approach is based upon the observation that low concentrations of one or more specifically chosen proteases cleave proteins into proteolytically stable domains amenable to NMR analysis or crystallography (Morin, P. E; et aL Proc.
- Limited proteolysis has been conducted to isolate and identify stable domains of proteins.
- the protein is incubated with four to six different proteases at different concentrations for different amounts of time.
- Typical protease digestion reactions are conducted by dissolving an enzyme in water thereby allowing the enzyme to act on a substrate in an aqueous solution.
- the fact that the enzyme reaction is a homogeneous reaction in an aqueous solution is a great hindrance to performance of a continuous reaction in industrial applications and also makes it very difficult to recover remaining active enzymes for repeated use after the reaction.
- complicated operational procedures are necessary for separation and purification of the reaction product.
- the digestion products can be analyzed by SDS/polyacrylamide gel electrophoresis and proteolytically stable fragments can be identified on the basis of approximate mass. These products can then be isolated by reverse phase chromatography and an accurate mass determination can be performed by mass spectrometry.
- the accurate mass of a proteolytic fragment is sufficient to uniquely identify the boundaries of the fragment within a sequence of a protein. The identification of the proteolytic fragment sequence facilitates the recombinant preparation of the domain in sufficient quantities for X-ray and NMR analysis.
- a limitation of the aforementioned strategy is the time consuming nature of cleaving, identifying and isolating the domains of a protein from the digestion solution.
- the present invention to provides a method and device to assist in the determination of protein domain boundaries.
- a method for the preparation of proteolytically digested fragments of a protein in one step for purification and further processing for determination of domains and their boundaries in the protein comprises a one step degradation of protein which comprises contacting a quantity of the protein with two or more concentrations of one or more immobilized proteases for a time sufficient to allow degradation of the protein to provide digested fragments and then separating the immobilized protease from the fragments.
- Each protease is immobilized in a compartment in an apparatus which comprises a plurality of compartments, each compartment containing a quantity of a protease immobilized on a surface in each compartment.
- each compartment contains a concentration of the protease distinct from the concentration of the protease in every other compartment.
- the surface upon which the protease is immobilized has been treated with a blocker of surface interaction.
- the protein is contacted with the protease in each compartment at about the same time.
- the method is automated allowing for simultaneous addition of a quantity of the protein to each of the compartments. Downstream automation removes protolytically treated fragments to a purification step to yield one or more samples for further processing and structure determination. Accordingly, the present invention provides a high throughput method and device for enzymatically cleaving proteins into domains which allows for an efficient means to identify protein domain boundaries for use in protein crystallization, in a manner that is amenable to automation.
- a device of the invention is connected downstream to an automatic means of adding a protein solution, or a solution of a protein fragment, and upstream to an automatic means of removing and subjecting the proteolytically digested product to a purification step.
- a method for determining the boundaries of a proteolytically digested fragment of a protein which comprises the steps: (i) incubating a protein, or a fragment thereof, with at least one immobilized protease to yield protein fragments; and (ii) subjecting the resulting protein fragments to one or more purification steps to isolate the fragment(s) of interest; (iii) subjecting the isolated fragment(s) to either nanospray or matrixassisted time-of-flight mass spectrometry; (iv) matching the mass of the proteolytic fragment to the protein sequence of the protein originally digested.
- an apparatus for degradation of a protein comprising a plurality of compartments, with at least two different concentrations of protease in separate compartments.
- each compartment contains a concentration of protease distinct from the concentration of protease in every other compartment.
- the present invention also includes a kit containing the device of the present invention together with appropriate reagents and instructions for its use.
- proteins domains have been determined by the methods of the present invention, these protein domains can be used in screens of protein-protein interaction, such as for example, by affinity chromatography.
- Advantages of the present invention include the primary factor that proteases and protease fragments do not substantially contaminate the proteolytically digested protein fragments as the proteases are immobilized and not in solution.
- Another advantage is the ability to re-use the treated plates. Another advantage is the reproducibility and as mentioned, high throughput of protease digestion.
- the ready use format of the present invention provides an immobilized product that: (1) is essentially unable to undergo autolytic cleavage; and (2) is essentially unable to degrade due to one protease cleaving another protease.
- FIG. 1 shows a comparison of PAGE results of a limited digestion of the transcription factor TFIIS from the yeast, Saccharomyces cerevisiae . in solution and in microtitre plates.
- FIG. 2 shows the PAGE results of samples of limited digestion of various proteins in microtitre plates by trypsin and chymotrypsin where A represents the results with RNA polymerase B5; B is RNA polymerase B6; C is RNA polymerase B8; and D is a bacterial protein parB.
- protein includes the terms “peptide” and “polypeptide” and includes a fragment of a protein as well as an amino acid chain which provides a fully constituted molecular structure such as the transcription factor TFIIS from the yeast, Saccharomyces cerevise.
- proteolytically digested protein means the degradation of a protein by an enzyme or protease and includes limited degradation of a protein by an enzyme or protease.
- solid support includes any substance which is capable of interacting with a protease or other enzyme and holding it out of solution, and includes for examples organic and inorganic support materials as described herein.
- compartment includes any structure which is capable of supporting an immobilized protease, for example, a well in a microtitre plate, a column containing a resin or other bead-like particle. It will be understood that there may be duplicates and triplicates of some concentrations within a plurality of compartments of an apparatus of the invention, so long as over all there are at least two or three different concentrations. Further, it is understood that a number of apparatuses of the invention may be used in parallel to create a super matrix with numerous repeats of a particular concentration all within one apparatus with each apparatus having differing concentrations of protease.
- the present invention provides a method for the preparation of proteolytically digested fragments of a protein, free of protease, for the determination of domains and the boundaries of the domains in said protein, the method comprises:
- the compartment is in an apparatus which comprises a plurality of compartments.
- compartment containing a quantity of the protease contains a concentration of the protease different from the concentration of the protease in every other compartment.
- concentration of the protease is in at least three different compartments.
- the plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in the compartments.
- the matrix contains more than one protease.
- the compartments form a matrix in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis.
- a protease for use in ta method of the invention is selected from the group consisting of aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin.
- the proteases are trypsin, chymotrypsin, proteinase K or papain.
- the concentrations of each of the proteases along the first axis in each case is from about 50 ⁇ g/mL to about 0.5 ⁇ g/mL. More preferably the concentration for each of the proteases is about 50 ⁇ g/mL in one container of a concentration axis; about 25 ⁇ g/mL in a second container of the concentration axis; about 5 ⁇ g/mL in a third container of the concentration axis; about 2.5 ⁇ g/mL in a fourth container of the concentration axis; about 0.5 ⁇ g/mL in a fifth container of the concentration axis; about 0 ⁇ g/mL in a sixth container of the concentration axis.
- a preferred embodiment of the method requires that the surface upon which the protease is immobilized has been treated with a blocker of surface interaction.
- the blocker is selected from the group consisting of BSA and beta-octyl glucoside.
- the surface to which the protease(s) is/are immobilized is selected from the group consisting of an organic support of material selected from the group consisting of polyesters, polyamides, polyacrylates, polymethacrylates, polyacrylamides, poly(acrylic acid)m, poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins; cellulose; cellulose derivatives; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and an inorganic support material selected from the group consisting of siliceous and nonsiliceous metal oxides.
- an organic support of material selected from the group consisting of polyesters, polyamides, polyacrylates, polymethacrylates, polyacrylamides, poly(acrylic acid)m, poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copo
- the apparatus is a microtitre plate and the time for incubation of protein with immobilized protease is between about 2 to 4 hours.
- the temperature for the reaction between immobilized protease and protein is room temperature. According one embodiment of the method only limited digestion of the protein occurs.
- proteolytically digested protein fragments substantially free of digesting protease by using proteases that are immobilized on a solid support such as a microtiter well. Coupling of the immobilized protease plates to a chromatographic step for separation of the protein fragments thereby generated, prepares the fragments for further analysis such as sequence determination or mass spectrometry.
- the design of the device allows for a high throughput of protein samples in addition to being particularly suitable for automation.
- the present invention provides a method for determining the boundaries of a proteolytically digested fragment of a protein which comprises the steps: (i) incubating a protein, according to the methods described herein to yield protein fragments; (ii) isolatation of fragments) of interest; (iii) determining the mass of the isolated fragment(s); and (iv) matching the mass of the proteolytic fragment(s) to a protein amino acid sequence of the protein digested.
- the determination of mass is by a method selected from the group consisting of nanospray time-of-flight mass spectrometry and matrix-assisted time-of-flight mass spectrometry.
- the protein fragment isolation is carried out by a technique selected from the group consisting of High Performance Liquid Chromatograph (HPLC) and sodium dodecylsulphate (SDS) polyacrylamide gel electrophoresis (PAGE).
- HPLC High Performance Liquid Chromatograph
- SDS sodium dodecylsulphate
- PAGE polyacrylamide gel electrophoresis
- protease plates allow highly parallel domain mapping.
- the plates with commercially available robotics, can be coupled with HPLC and mass spectrometry to make an integrated system for the rapid molecular identification of protein domains.
- An apparatus of the present invention can be used to treat a protein solution containing whole proteins or fragments thereof to limited proteolysis to generate stable domains of the proteins for further analysis.
- the present invention provides an apparatus for degradation of a protein, where the apparatus comprises a plurality of compartments, each compartment containing a quantity of a protease immobilized on a surface in each compartment wherein at least two compartments contain different concentrations of the protease.
- each of the compartments of the apparatus contain a concentration of the protease different from the concentration of the protease in every other compartment.
- an apparatus contains at least three concentrations of protease in three compartments.
- a plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in at least three of the compartments.
- the apparatus contains more than one protease.
- a plurality of compartments forms a matrix in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis.
- an apparatus is a microtitre plate.
- a “microtitre plate” as referred to herein is well known to those skilled in the art and is a sample plate having one or more wells for receipt of a sample, the microtitre plate being suitable for use in an automated process.
- a plate well within a single microtitre plate can contain one or more proteases at a single concentration or differing concentrations or be a control blank. Due to the open layout of the microtiter wells, and the matrix of proteolytic enzymes, the design of the device permits a high throughput level of protein treatment that significantly diminishes the time required for an equivalent digestion procedure that is familiar in the art.
- such plates typically contain 96 wells, but higher volume plates such as 380 or more are also contemplated to function in the present invention.
- proteases can be used, both alkaline and acidic. Moreover, given the existence of a multitude of known proteases and the application of recombinant DNA technology to the study and production of protease analogs, the art has yet to develop completely.
- proteases are available and can be used in this device and procedure, for example: aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin.
- the proteases are trypsin, chymotrypsin, proteinase K or papain.
- a single plate has six or more different immobilized proteases.
- Each protease is dispensed along a single row, with the concentration in the first well at 50 micrograms per millilitre and each subsequent well with a two-fold dilution.
- an apparatus according to the present invention has concentrations of each of the proteases along the first axis from about 50 ⁇ g/mL to about 0.5 ⁇ g/mL.
- the concentration for each of the proteases is about 50 ⁇ g/mL in one container of a concentration axis; about 25 ⁇ g/mL in a second container of the concentration axis; about 5 ⁇ g/mL in a third container of the concentration axis; about 2.5 ⁇ g/mL in a fourth container of the concentration axis; about 0.5 ⁇ g/mL in a fifth container of the concentration axis; about 0 ⁇ g/mL in a sixth container of the concentration axis.
- the surface upon which the protease(s) is are immobilized has been treated with a blocker of surface interaction where the blocker is selected from the group consisting of BSA and beta-octyl glucoside.
- An apparatus of the invention can be stored for a period of at least a week, at 4° C. Preferably before storage the apparatus is lyophilized.
- Immobilization of the enzyme on the solid support is readily accomplished by various methods which are known.
- Various methods are known for immobilization of enzymes (refer to, for example, O. R. Zaborsky, “Immobilized Enzymes”, C.R.C. Press, 1973 ; or “Immobilized Enzymes”, edited by Ichiro Chihata, Kodansha, 1975; see also see I. Chibata, Editor, “Immobilized Enzymes”, Halsted Press, John Wiley & Sons, Inc., New York, 1978, pp. 1-73). They can roughly be classified into the following four groups: (1) physical or ionic adsorption method; (2) covalent attachment method; (3) entrapment method; and (4) crosslking method.
- the device is generated by immobilizing the proteases by overnight incubation at room temperature.
- the solid support generally can be either organic or inorganic.
- organic supports include, among others, polyesters, such as poly(ethylene terephthalate); polyamides, such as nylon 6 and nylon 6.6; polyacrylates; polymethacrylates; polyacrylamides; poly(acrylic acid); poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins, such as polyethylene, polypropylene, polybutene, and polybutadiene; polystyrene; poly(aminostyrene); poly(vinyl chloride); poly(vinyl alcohol); poly(vinylidene chloride); cellulose and derivatives thereof; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and the like.
- the inorganic supports can be classified as siliceous or nonsiliceous metal oxides.
- siliceous supports include, among others, glass, silica, wollastonite, bentonite, cordierite, and the like.
- nonsiliceous metal oxides include, among others, alumina, spinel, apatite, nickel oxide, titania, zirconia, and the like.
- the support can be in any desired shape or form that is a continuous, shaped article such as a flat or curved sheet or a three-dimensional article such as a rectangular or cylindrical tube.
- the support most often will be a microtiter plate or a similar shaped support.
- the non-specific binding sites on the microtitre wells are blocked for a period of time (three hours) with an appropriate blocking solution containing 0.1% betaoctylglucoside, although depending upon the support material chosen other blockers will be preferred, such as for example bovine serum albumin (BSA).
- BSA bovine serum albumin
- the present invention relates to a kit for conducting limited proteolysis digestion of proteins or protein fragments for structure determination analysis comprising at least one container including the above-described device.
- the proteolysis device can be presented in a commercially packaged form, a packaged combination of one or more containers, devices, or the like, holding the necessary reagents and usually including written instructions describing the performance of the digestion procedure.
- Reagent systems of the present invention involve all possible configurations and compositions for performing the various digestion formats described herein.
- the kit further comprises other containers comprising one or more of the following: wash reagents, dilution reagents, proteolysis stopping reagents and control proteins with known digestion patterns and instructions for use of the kit.
- a compartmentalized kit includes any kit in which reagents are contained in separated containers.
- Such containers include glass or plastic containers or strips of plastic or paper.
- Such containers allow the efficient transfer of reagents from one compartment to another compartment such that the samples and reagents are not cross-contaminated and the agents or solutions of each container can be added in a quantitative fashion from one compartment or another.
- Such containers will include a container which will accept the microtiter plate, a container which contains wash reagents and proteolysis stopping reagents (eg. acetic acid).
- the kit will include the materials to prepare a device of the present invention, which would therefore, include proteolytic enzymes, blocking reagents and buffer materials.
- proteolytic enzymes include the materials to prepare a device of the present invention, which would therefore, include proteolytic enzymes, blocking reagents and buffer materials.
- the proteolysis device of the present invention can readily be incorporated into one of the established kit formats which are well known in the art.
- proteolytic enzymes are immobilized on a microtiter plate.
- the reagents were prepared as follows. A buffer solution of TBS, 50 mM Tris pH 8.0, 150 mM NaCl is prepared for use with the remaining solutions. A solution of TBS, 0.01% beta-octa-glucoside is prepared as a blocking buffer. The following proteases are prepared: Chymotrypsin, 0.5 mg/ml (in TBS); Trypsin, 0.5 mg/ml (in TBS); Papain, 0.5 mg/ml (in TBS); and Proteinase K, 0.5 mg/ml (in TBS). The protein to be digested is prepared at 65 ⁇ g/ml (diluted in TBS).
- the protease solution is removed from the wells by flicking the plate a few times while inverted.
- the wells are washed once with blocking buffer (100 ⁇ l) and the excess solution is removed. 100 ⁇ l of blocking buffer is added and incubate for 30 minutes at 4° C.
- the blocking buffer is removed and the wells are washed once (100 ⁇ l) with TBS and the excess TBS is removed.
- the plates are now ready for use or can be lyophilized and stored at ⁇ 20° C. until needed.
- the proteolysis of protein is stopped by adding 5 ⁇ protein loading dye to each well.
- the sample in each well is heated to approximately 90° C. for approximately 5 minutes.
- 20-25 ⁇ l of the sample is loaded onto a SDS PAGE gradient gel (5-18%), and run under electrophoresis followed by a Commassie stain to visualize the protein fragments.
- FIG. 1 Shown in FIG. 1 is an example of a limited digestion of the transcription factor TFIIS from the yeast, Saccharomyces cerevisiae .
- the five lanes shown correspond to the concentration of proteases used (as discussed above in Example I).
- RNA polymerase B5 illustrates results of digestion on immobilized protease plates of RNA polymerase B5 (see A); RNA polymerase B6 (B); RNA polymerase B8 (C); and D is a bacterial protein parB.
- Each of these four proteins were digestd by trypsin (panels on the left) and chymotrypsin (panels on the right). These digests compare favourably with similar digests in solution (data not shown).
- proteases trypsin, chymotrypsin, papain and proteinase K (Sigma) were immobilized on plastic 96-well microtitre plates (Nuclon) in the following manner.
- the protease stocks were made 0.5 mg/ml in TBS (50 mM Tris pH 8, 150 mM NaCl).
- a serial dilution of each protease was prepared to final concentrations of 50 ⁇ g/ml, 25 ⁇ g/ml, 5 ⁇ g/ml, 2.5 ⁇ g/ml and 0.5 ⁇ g/ml in TBS. 50 ⁇ l of each dilution was applied to different wells in a row of the microtitre plate.
- the plate with the arrayed protease dilutions was then incubated overnight at 4° C. in a sealed bag containing a wet paper towel.
- the protease solution was then removed and the wells washed with 100 ⁇ l of blocking buffer (TBS, 0.01% beta-octyl glucoside). The first wash was discarded and the non-specific binding sites on the microtitre wells were blocked with an additional 30 minute incubation at 4° C. with an additional 100 ⁇ l of blocking buffer. 30 ⁇ l of a solution of yeast TFIIS (65 ⁇ g/ml) was incubated in each of the protease-coated wells for 2-4 hours at room temperature.
- TBS blocking buffer
- yeast TFIIS 65 ⁇ g/ml
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
A method and device to assist in the determination of protein domain boundaries is described. In particular the device is designed to provide a high throughput of proteolytic digestion of proteins to identify domains and their boundaries, for use in protein structure determination, in a manner that is amenable to automation. Proteases are immobilized in a convenient format such as a microtitre plate and preferably arranged in a matrix thereby allowing for simultaneous degradation of a protein by a number of proteases at a number of concentrations.
Description
- The present invention generally relates to methods for determination of protein structure and in particular concerns the use of immobilized proteases to identify domain boundaries of proteins, and an apparatus for digesting proteins.
- The molecular structure of proteins allows them play crucial roles in virtually all biological processes, including: enzymatic catalysis, transport and storage; coordinated motion; mechanical support; immune protection; generation and transmission of nerve impulses; and control of growth and differentiation. In particular, the side chains of the different amino acids that comprise proteins, enables these long macromolecules to fold into distinctive structures and form complementary surfaces and clefts and enables them to specifically recognize and interact with highly diverse molecules. The catalytic power of enzymes comes from their capacity to bind substrates in precise orientations and to stabilize transition states in the making and breaking of chemical bonds. Conformational changes transmitted between distant sites in protein molecules are at the heart of the capacity of proteins to transduce energy and information. Thus, the three dimensional structure of a protein is the key to its ability to function in virtually all biological processes.
- Discussions pertaining to protein architecture concern four levels of structure which are described as follows. Primary structure is the amino acid sequence. Secondary structure refers to the spatial arrangement of amino acid residues that are near one another in the linear sequence. Some of these steric relationships are of a regular kind, giving rise to a periodic structure. Tertiary structure refers to the spatial arrangement of amino acid residues that are far apart in the linear sequence, and to the pattern of disulfide bonds. The term, quaternary structure, refers to proteins containing more than one polypeptide chain where each polypeptide chain is referred to as a subunit, and the quaternary structure refers to the spatial arrangement subunits and the nature of their contacts.
- Some polypeptide chains fold into two or more compact regions that may be joined by a flexible segment of polypeptide chain. These compact globular units, called domains, range in size from about 50 to 400 amino acid residues, and they seem to be the modular units from which proteins are constructed. While small proteins may contain only a single domain, larger proteins contain a number of domains, which are often connected by relatively open lengths of polypeptide chain. Although all information required for folding a protein chain is contained in the protein's amino acid sequence, it is not yet known how to “read” this information so as to predict the detailed three-dimensional structure of a protein whose sequence is known. Consequently, folded conformation currently can only be determined by an elaborate X-ray diffraction analysis performed on crystals of the protein or, if the protein is very small, by nuclear magnetic resonance (“NMR”) techniques. Although considerable advances are being made in the area of high field NMR, presently, the only method capable of producing a highly accurate three dimensional structure of most proteins is by the application of X-ray crystallography.
- Recent advances in the field of X-ray crystallography, such as high speed computer graphics and X-ray area detection technologies, have revolutionized the pace at which three-dimensional structures can be determined. The resulting three dimensional structure produced from the protein crystals can have enormous implications in the fundamental understanding of molecular biology such as how enzymes perform various catalytic activities, switch on biological pathways, or transport molecules within the circulatory system. In the past few years the determination of protein structures important as therapeutic targets has made possible the rational design of new, more effective pharmaceuticals.
- The technique of X-ray crystallography utilizes the diffraction of X-rays from crystals in order to determine the precise arrangement of atoms within the crystal. The limiting step in the technique involves the growth of a suitable crystalline sample. This requires the growth of reasonably ordered protein crystals (crystals which diffract X-rays to at least 3.0 angstroms resolution or less).
- Because of the complexity of proteins, obtaining suitable crystals can be quite difficult. Typically, several hundred to several thousand individual experiments must be performed to determine crystallization conditions, each examining a matrix of pH, buffer type, precipitant type, protein concentration, temperature, etc. This process is extremely time consuming and labour intensive.
- A strategic approach has been developed to identify protein domains that are amenable to NMR analysis or X-ray crystallography. Different domains of a protein may be linked together by intervening sections of polypeptide chain to form the protein molecule. Analysis of a single domain is more easily conducted in isolation from its parent protein. The determination of an individual domain structure facilitates elucidation of the parent structure. Limited proteolysis has been used to isolate and identify stable domains of proteins, which have a high likelihood of being good targets for protein structure determination. The approach is based upon the observation that low concentrations of one or more specifically chosen proteases cleave proteins into proteolytically stable domains amenable to NMR analysis or crystallography (Morin, P. E; et aL Proc. Nad. Acad. Sci. 1996, 93, 10604-10608; Barswell, J. A.; et al. J. Bio. Chem. 1995, 270, 20556-20559; Pfuetzner, R. A; et al. J. Bio. Chem. 1997, 272, 430-434; and Malhotra, A; el aL Cell 1996, 87, 127-136).
- Limited proteolysis has been conducted to isolate and identify stable domains of proteins. Generally, according to this process, the protein is incubated with four to six different proteases at different concentrations for different amounts of time. Typical protease digestion reactions are conducted by dissolving an enzyme in water thereby allowing the enzyme to act on a substrate in an aqueous solution. However, the fact that the enzyme reaction is a homogeneous reaction in an aqueous solution is a great hindrance to performance of a continuous reaction in industrial applications and also makes it very difficult to recover remaining active enzymes for repeated use after the reaction. In addition, complicated operational procedures are necessary for separation and purification of the reaction product.
- The digestion products can be analyzed by SDS/polyacrylamide gel electrophoresis and proteolytically stable fragments can be identified on the basis of approximate mass. These products can then be isolated by reverse phase chromatography and an accurate mass determination can be performed by mass spectrometry. The accurate mass of a proteolytic fragment is sufficient to uniquely identify the boundaries of the fragment within a sequence of a protein. The identification of the proteolytic fragment sequence facilitates the recombinant preparation of the domain in sufficient quantities for X-ray and NMR analysis.
- A limitation of the aforementioned strategy is the time consuming nature of cleaving, identifying and isolating the domains of a protein from the digestion solution.
- The present invention to provides a method and device to assist in the determination of protein domain boundaries. In accordance with an aspect of the invention there is provided a method for the preparation of proteolytically digested fragments of a protein in one step for purification and further processing for determination of domains and their boundaries in the protein, The method developed by present inventor comprises a one step degradation of protein which comprises contacting a quantity of the protein with two or more concentrations of one or more immobilized proteases for a time sufficient to allow degradation of the protein to provide digested fragments and then separating the immobilized protease from the fragments. Each protease is immobilized in a compartment in an apparatus which comprises a plurality of compartments, each compartment containing a quantity of a protease immobilized on a surface in each compartment. According to a preferred embodiment each compartment contains a concentration of the protease distinct from the concentration of the protease in every other compartment. Preferrably the surface upon which the protease is immobilized has been treated with a blocker of surface interaction. The protein is contacted with the protease in each compartment at about the same time.
- In accordance with a further aspect of the invention the method is automated allowing for simultaneous addition of a quantity of the protein to each of the compartments. Downstream automation removes protolytically treated fragments to a purification step to yield one or more samples for further processing and structure determination. Accordingly, the present invention provides a high throughput method and device for enzymatically cleaving proteins into domains which allows for an efficient means to identify protein domain boundaries for use in protein crystallization, in a manner that is amenable to automation.
- In accordance with one aspect of the present invention a device of the invention is connected downstream to an automatic means of adding a protein solution, or a solution of a protein fragment, and upstream to an automatic means of removing and subjecting the proteolytically digested product to a purification step.
- In accordance with another aspect of the present invention there is provided a method for determining the boundaries of a proteolytically digested fragment of a protein which comprises the steps: (i) incubating a protein, or a fragment thereof, with at least one immobilized protease to yield protein fragments; and (ii) subjecting the resulting protein fragments to one or more purification steps to isolate the fragment(s) of interest; (iii) subjecting the isolated fragment(s) to either nanospray or matrixassisted time-of-flight mass spectrometry; (iv) matching the mass of the proteolytic fragment to the protein sequence of the protein originally digested.
- According to another aspect of the present invention there is provided an apparatus for degradation of a protein, where the apparatus comprises a plurality of compartments, with at least two different concentrations of protease in separate compartments. In a preferred embodiment each compartment contains a concentration of protease distinct from the concentration of protease in every other compartment.
- The present invention also includes a kit containing the device of the present invention together with appropriate reagents and instructions for its use.
- Once proteins domains have been determined by the methods of the present invention, these protein domains can be used in screens of protein-protein interaction, such as for example, by affinity chromatography.
- Advantages of the present invention include the primary factor that proteases and protease fragments do not substantially contaminate the proteolytically digested protein fragments as the proteases are immobilized and not in solution.
- Another advantage is the ability to re-use the treated plates. Another advantage is the reproducibility and as mentioned, high throughput of protease digestion.
- Because many devices can be generated at the same time, there is an efficiency of production and consistency of immobilized protease concentration that can be attained by this invention that is not currently available in the art. Some of the plates with an immobilized protease can be mass produced and stored for at least one week, at 4° C., while maintaining activity. Plates can be manufactured as standards or as custom models as requested.
- In contrast to autolytic proteases (and mixtures of proteases that can degrade due to one protease cleaving another protease, in solution), the ready use format of the present invention provides an immobilized product that: (1) is essentially unable to undergo autolytic cleavage; and (2) is essentially unable to degrade due to one protease cleaving another protease.
- FIG. 1 shows a comparison of PAGE results of a limited digestion of the transcription factor TFIIS from the yeast,Saccharomyces cerevisiae. in solution and in microtitre plates.
- FIG. 2 shows the PAGE results of samples of limited digestion of various proteins in microtitre plates by trypsin and chymotrypsin where A represents the results with RNA polymerase B5; B is RNA polymerase B6; C is RNA polymerase B8; and D is a bacterial protein parB.
- Current limitations in the art of identifying stable domains of proteins for use in structure determination are overcome by use of this invention which provides a device and method for conducting limited proteolysis of proteins to identify protein domains useful for structure determination. In particular the device is designed to provide a high throughput of proteolytic digestion of proteins to identify domains and their boundaries, for use in protein structure determination, in a manner that is amenable to automation.
- As used herein the word “protein” includes the terms “peptide” and “polypeptide” and includes a fragment of a protein as well as an amino acid chain which provides a fully constituted molecular structure such as the transcription factor TFIIS from the yeast,Saccharomyces cerevise.
- As used herein, the phrase “proteolytically digested protein” means the degradation of a protein by an enzyme or protease and includes limited degradation of a protein by an enzyme or protease.
- As used herein the phrase “solid support” includes any substance which is capable of interacting with a protease or other enzyme and holding it out of solution, and includes for examples organic and inorganic support materials as described herein.
- As used herein “compartment” includes any structure which is capable of supporting an immobilized protease, for example, a well in a microtitre plate, a column containing a resin or other bead-like particle. It will be understood that there may be duplicates and triplicates of some concentrations within a plurality of compartments of an apparatus of the invention, so long as over all there are at least two or three different concentrations. Further, it is understood that a number of apparatuses of the invention may be used in parallel to create a super matrix with numerous repeats of a particular concentration all within one apparatus with each apparatus having differing concentrations of protease.
- Method of the Invention
- The present invention provides a method for the preparation of proteolytically digested fragments of a protein, free of protease, for the determination of domains and the boundaries of the domains in said protein, the method comprises:
- (1) contacting a quantity of the protein with at least two concentrations of a protease under conditions which result in digested fragments of the protein, wherein each of the concentrations of protease is immobilized in a separate compartment; and
- (2) separating said fragments from the immobilized protease. Preferably the compartment is in an apparatus which comprises a plurality of compartments.
- According to one embodiment of the method compartment containing a quantity of the protease contains a concentration of the protease different from the concentration of the protease in every other compartment. Preferably at least three concentrations of protease are in at least three different compartments.
- According to another embodiment the plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in the compartments. Preferably the matrix contains more than one protease.
- According to a preferred embodiment of the method the compartments form a matrix in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis.
- A protease for use in ta method of the invention is selected from the group consisting of aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin. Preferably the proteases are trypsin, chymotrypsin, proteinase K or papain.
- According to a preferred embodiment the concentrations of each of the proteases along the first axis in each case is from about 50 μg/mL to about 0.5 μg/mL. More preferably the concentration for each of the proteases is about 50 μg/mL in one container of a concentration axis; about 25 μg/mL in a second container of the concentration axis; about 5 μg/mL in a third container of the concentration axis; about 2.5 μg/mL in a fourth container of the concentration axis; about 0.5 μg/mL in a fifth container of the concentration axis; about 0 μg/mL in a sixth container of the concentration axis.
- A preferred embodiment of the method requires that the surface upon which the protease is immobilized has been treated with a blocker of surface interaction. Preferably the blocker is selected from the group consisting of BSA and beta-octyl glucoside.
- According to another aspect of the method the surface to which the protease(s) is/are immobilized is selected from the group consisting of an organic support of material selected from the group consisting of polyesters, polyamides, polyacrylates, polymethacrylates, polyacrylamides, poly(acrylic acid)m, poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins; cellulose; cellulose derivatives; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and an inorganic support material selected from the group consisting of siliceous and nonsiliceous metal oxides.
- In a preferred embodiment of the method the apparatus is a microtitre plate and the time for incubation of protein with immobilized protease is between about 2 to 4 hours. Preferably the temperature for the reaction between immobilized protease and protein is room temperature. According one embodiment of the method only limited digestion of the protein occurs.
- Accordingly carrying out the method of the present invention provides proteolytically digested protein fragments substantially free of digesting protease by using proteases that are immobilized on a solid support such as a microtiter well. Coupling of the immobilized protease plates to a chromatographic step for separation of the protein fragments thereby generated, prepares the fragments for further analysis such as sequence determination or mass spectrometry. The design of the device allows for a high throughput of protein samples in addition to being particularly suitable for automation. As such the present invention provides a method for determining the boundaries of a proteolytically digested fragment of a protein which comprises the steps: (i) incubating a protein, according to the methods described herein to yield protein fragments; (ii) isolatation of fragments) of interest; (iii) determining the mass of the isolated fragment(s); and (iv) matching the mass of the proteolytic fragment(s) to a protein amino acid sequence of the protein digested. Preferably the determination of mass is by a method selected from the group consisting of nanospray time-of-flight mass spectrometry and matrix-assisted time-of-flight mass spectrometry. Also, preferably the protein fragment isolation is carried out by a technique selected from the group consisting of High Performance Liquid Chromatograph (HPLC) and sodium dodecylsulphate (SDS) polyacrylamide gel electrophoresis (PAGE). The loading and transference of the protein samples to the device and, following the reaction, to a detector such as HPLC or mass spectrometer, can be performed by automated means known in the art. According to a preferred embodiment the method is automated.
- Automated sampling and automated transfer and mixing of solutions and solvents is routine. Many commercial automated apparatuses are available and save considerable hours and days of sample manipulation. For example, auto samplers for HPLC, gas chromatography and mass spectrometry are all commercially available. In addition, commercial solution handling devices are readily customised to suit the users needs. The employment of such automated handlers in conjunction with protease immobilized plates removes the steps of manipulating a protease solution and subsequent removal of unwanted protease reagent and protease fragments.
- The use of the protease plates allows highly parallel domain mapping. The plates, with commercially available robotics, can be coupled with HPLC and mass spectrometry to make an integrated system for the rapid molecular identification of protein domains.
- Apparatus of the Invention
- An apparatus of the present invention can be used to treat a protein solution containing whole proteins or fragments thereof to limited proteolysis to generate stable domains of the proteins for further analysis. Accordingly the present invention provides an apparatus for degradation of a protein, where the apparatus comprises a plurality of compartments, each compartment containing a quantity of a protease immobilized on a surface in each compartment wherein at least two compartments contain different concentrations of the protease. Preferrably each of the compartments of the apparatus contain a concentration of the protease different from the concentration of the protease in every other compartment.
- According to a preferred embodiment an apparatus according to the present invention contains at least three concentrations of protease in three compartments. Preferably a plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in at least three of the compartments. More preferably the apparatus contains more than one protease.
- According to another embodiment of an apparatus of the present invention a plurality of compartments forms a matrix in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis.
- According to a preferred embodiment an apparatus according to the present invention is a microtitre plate. A “microtitre plate” as referred to herein is well known to those skilled in the art and is a sample plate having one or more wells for receipt of a sample, the microtitre plate being suitable for use in an automated process. A plate well within a single microtitre plate can contain one or more proteases at a single concentration or differing concentrations or be a control blank. Due to the open layout of the microtiter wells, and the matrix of proteolytic enzymes, the design of the device permits a high throughput level of protein treatment that significantly diminishes the time required for an equivalent digestion procedure that is familiar in the art. Typically, such plates contain 96 wells, but higher volume plates such as 380 or more are also contemplated to function in the present invention.
- On such microtitre plates a protease digestion matrix is generated with different proteases along one axis and increasing concentrations along the other axis.
- Different proteases can be used, both alkaline and acidic. Moreover, given the existence of a multitude of known proteases and the application of recombinant DNA technology to the study and production of protease analogs, the art has yet to develop completely. Many proteases are available and can be used in this device and procedure, for example: aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin. Preferably the proteases are trypsin, chymotrypsin, proteinase K or papain.
- The larger the number of proteases with different specificity, the greater the procedural flexibility provided by one or more microtitre plates. In a preferred embodiment a single plate has six or more different immobilized proteases. Each protease is dispensed along a single row, with the concentration in the first well at 50 micrograms per millilitre and each subsequent well with a two-fold dilution. According to a preferred embodiment an apparatus according to the present invention has concentrations of each of the proteases along the first axis from about 50 μg/mL to about 0.5 μg/mL. More preferably the concentration for each of the proteases is about 50 μg/mL in one container of a concentration axis; about 25 μg/mL in a second container of the concentration axis; about 5 μg/mL in a third container of the concentration axis; about 2.5 μg/mL in a fourth container of the concentration axis; about 0.5 μg/mL in a fifth container of the concentration axis; about 0 μg/mL in a sixth container of the concentration axis. Preferably the surface upon which the protease(s) is are immobilized has been treated with a blocker of surface interaction where the blocker is selected from the group consisting of BSA and beta-octyl glucoside.
- An apparatus of the invention can be stored for a period of at least a week, at 4° C. Preferably before storage the apparatus is lyophilized.
- Immobilization of the enzyme on the solid support is readily accomplished by various methods which are known. Various methods are known for immobilization of enzymes (refer to, for example, O. R. Zaborsky, “Immobilized Enzymes”, C.R.C. Press,1973; or “Immobilized Enzymes”, edited by Ichiro Chihata, Kodansha, 1975; see also see I. Chibata, Editor, “Immobilized Enzymes”, Halsted Press, John Wiley & Sons, Inc., New York, 1978, pp. 1-73). They can roughly be classified into the following four groups: (1) physical or ionic adsorption method; (2) covalent attachment method; (3) entrapment method; and (4) crosslking method.
- In a preferred embodiment, the device is generated by immobilizing the proteases by overnight incubation at room temperature.
- The solid support generally can be either organic or inorganic. Examples of organic supports include, among others, polyesters, such as poly(ethylene terephthalate); polyamides, such as nylon 6 and nylon 6.6; polyacrylates; polymethacrylates; polyacrylamides; poly(acrylic acid); poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins, such as polyethylene, polypropylene, polybutene, and polybutadiene; polystyrene; poly(aminostyrene); poly(vinyl chloride); poly(vinyl alcohol); poly(vinylidene chloride); cellulose and derivatives thereof; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and the like.
- The inorganic supports can be classified as siliceous or nonsiliceous metal oxides. Examples of siliceous supports include, among others, glass, silica, wollastonite, bentonite, cordierite, and the like. Examples of nonsiliceous metal oxides include, among others, alumina, spinel, apatite, nickel oxide, titania, zirconia, and the like.
- In general, the support can be in any desired shape or form that is a continuous, shaped article such as a flat or curved sheet or a three-dimensional article such as a rectangular or cylindrical tube. As a practical matter, however, the support most often will be a microtiter plate or a similar shaped support.
- For examples of procedures for immobilizing enzymes on inorganic supports, by way of illustration only, see U.S. Pat. No. 3,519,538 (which corresponds with French Patent No. 2,020,527), U.S. Pat. No. 3,556,945 (which corresponds with French Patent No. 2,001,336), and U.S. Pat. Nos. 3,666,627 and 3,802,997 (which correspond with French Patent No. 2,020,661).
- In a preferred embodiment, the non-specific binding sites on the microtitre wells are blocked for a period of time (three hours) with an appropriate blocking solution containing 0.1% betaoctylglucoside, although depending upon the support material chosen other blockers will be preferred, such as for example bovine serum albumin (BSA).
- Kit
- In another embodiment, the present invention relates to a kit for conducting limited proteolysis digestion of proteins or protein fragments for structure determination analysis comprising at least one container including the above-described device. The proteolysis device can be presented in a commercially packaged form, a packaged combination of one or more containers, devices, or the like, holding the necessary reagents and usually including written instructions describing the performance of the digestion procedure. Reagent systems of the present invention involve all possible configurations and compositions for performing the various digestion formats described herein.
- In a preferred embodiment, the kit further comprises other containers comprising one or more of the following: wash reagents, dilution reagents, proteolysis stopping reagents and control proteins with known digestion patterns and instructions for use of the kit.
- In detail, a compartmentalized kit includes any kit in which reagents are contained in separated containers. Such containers include glass or plastic containers or strips of plastic or paper. Such containers allow the efficient transfer of reagents from one compartment to another compartment such that the samples and reagents are not cross-contaminated and the agents or solutions of each container can be added in a quantitative fashion from one compartment or another. Such containers will include a container which will accept the microtiter plate, a container which contains wash reagents and proteolysis stopping reagents (eg. acetic acid).
- In an alternative embodiment, the kit will include the materials to prepare a device of the present invention, which would therefore, include proteolytic enzymes, blocking reagents and buffer materials. One skilled in the art will readily recognize that the proteolysis device of the present invention can readily be incorporated into one of the established kit formats which are well known in the art.
- The following non-limiting examples are illustrative of the present invention:
- General Experimental Protocol for Immobilizing Proteases on Microtiter Plates
- In this example, four proteolytic enzymes are immobilized on a microtiter plate.
- Reagents
- The reagents were prepared as follows. A buffer solution of TBS, 50 mM Tris pH 8.0, 150 mM NaCl is prepared for use with the remaining solutions. A solution of TBS, 0.01% beta-octa-glucoside is prepared as a blocking buffer. The following proteases are prepared: Chymotrypsin, 0.5 mg/ml (in TBS); Trypsin, 0.5 mg/ml (in TBS); Papain, 0.5 mg/ml (in TBS); and Proteinase K, 0.5 mg/ml (in TBS). The protein to be digested is prepared at 65 μg/ml (diluted in TBS).
- Preparation of Immobilized Protease Plate
- In this example of device preparation, Nunclon surface 96 well microtiter plates are used. The proteases are immobilized onto the plates by aliquotting 45 μl TBS into each well. Six wells are used for each protease to generate a series for each protease, each series operating at decreasing concentrations across the wells by adding 5 μl of protease stock solution to the first well, 2.5 μl to the second well, etc. The serial dilution of the wells yield final concentrations of proteases of 50 μg/ml, 25 μg/ml, 5 μg/ml, 2.5 μg/ml, and 0.5 μg/ml. The last well is left for protein only. The plate is covered and placed in a sealable bag with a wet paper towel. The resulting plate is incubated overnight at 4° C.
- Blocking of Non-Specific Sites on Microtiter Plate
- The protease solution is removed from the wells by flicking the plate a few times while inverted. The wells are washed once with blocking buffer (100 μl) and the excess solution is removed. 100 μl of blocking buffer is added and incubate for 30 minutes at 4° C. The blocking buffer is removed and the wells are washed once (100 μl) with TBS and the excess TBS is removed. The plates are now ready for use or can be lyophilized and stored at −20° C. until needed.
- Digestion of an Protein by an Immobilized Protease
- 30 μl of the protein solution of interest is added to each well. The resulting plate is then incubated at room temperature for 2-4 hours.
- Analysis of Proteolytically Digested Protein
- If the protein fragments are to be separated and analyzed by Mass Spectrometry, it is necessary to remove a sample of a proteolytically digested protein (5-10 μL) and stop the proteolysis by adding acetic acid to the sample until a final concentration of 1% is reached.
- If the protein fragments are to be separated and analyzed by SDS PAGE Gel Electrophoresis, the proteolysis of protein is stopped by adding 5×protein loading dye to each well. The sample in each well is heated to approximately 90° C. for approximately 5 minutes. 20-25 μl of the sample is loaded onto a SDS PAGE gradient gel (5-18%), and run under electrophoresis followed by a Commassie stain to visualize the protein fragments.
- Comparison of Immobilized Protease Digestion to Solution Protease Digestion
- The protease plates were used to digest five different proteins whose proteolytic digestion pattern in solution was already known. The pattern of digestion for the immobilized proteases mimicked the solution digestion pattern. Thus, we have shown that the immobilized proteases plates could be used to identify stable domains of several different proteins. Shown in FIG. 1 is an example of a limited digestion of the transcription factor TFIIS from the yeast,Saccharomyces cerevisiae. The five lanes shown correspond to the concentration of proteases used (as discussed above in Example I). FIG. 2 illustrates results of digestion on immobilized protease plates of RNA polymerase B5 (see A); RNA polymerase B6 (B); RNA polymerase B8 (C); and D is a bacterial protein parB. Each of these four proteins were digestd by trypsin (panels on the left) and chymotrypsin (panels on the right). These digests compare favourably with similar digests in solution (data not shown).
- Limited Proteolysis
- Four different proteases, trypsin, chymotrypsin, papain and proteinase K (Sigma) were immobilized on plastic 96-well microtitre plates (Nuclon) in the following manner. The protease stocks were made 0.5 mg/ml in TBS (50 mM Tris pH 8, 150 mM NaCl). A serial dilution of each protease was prepared to final concentrations of 50 μg/ml, 25 μg/ml, 5 μg/ml, 2.5 μg/ml and 0.5 μg/ml in TBS. 50 μl of each dilution was applied to different wells in a row of the microtitre plate. The plate with the arrayed protease dilutions was then incubated overnight at 4° C. in a sealed bag containing a wet paper towel.
- The protease solution was then removed and the wells washed with 100 μl of blocking buffer (TBS, 0.01% beta-octyl glucoside). The first wash was discarded and the non-specific binding sites on the microtitre wells were blocked with an additional 30 minute incubation at 4° C. with an additional 100 μl of blocking buffer. 30 μl of a solution of yeast TFIIS (65 μg/ml) was incubated in each of the protease-coated wells for 2-4 hours at room temperature. 5 μl of the protein solution was then made to 2% Sodium dodecyl sulphate, 25% glycerol, 0.1M Tris-Hel (pH 8.0) and resolved by gel electrophoresis. The results from a typical digestion (chymotrypsin) are shown in FIG. 1. The individual proteolytic products were purified either by reverse-phase liquid chromatography or by elution from the gel slice and were analyzed by matrix-assisted desorption time-of-flight mass spectrometry. The fragments corresponded to known domains of the yeast TFIIS (Proc. Nat. Acad. Sci. U.S.A. 93: 10604-10608, 1996).
- Stability
- Experiments with plates containing immobilized proteases lyophilized and stored at 4 degrees celcius for up to one week demonstrated results similar to those freshly prepared (data not shown).
- While the present invention has been described with reference to what are presently considered to be the preferred examples, it is to be understood that the invention is not limited to the disclosed examples. To the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
- All publications, patents and patent applications are herein incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety.
Claims (38)
1. A method for the preparation of proteolytically digested fragments of a protein, free of protease, for the determination of domains and the boundaries of the domains in said protein, the method comprises:
(1) contacting a quantity of said protein with at least two concentrations of a protease under conditions which result in digested fragments of said protein, wherein each of said concentrations of protease is immobilized in a separate compartment; and
(2) separating said fragments from said immobilized protease.
2. A method according to claim 1 wherein said compartment is in an apparatus which comprises a plurality of compartments.
3. A method according to claim 2 wherein each compartment containing a quantity of said protease contains a concentration of said protease distinct from the concentration of said protease in every other compartment.
4. A method according to claim 3 wherein at least three concentrations of protease are each in one of at least three different said compartments.
5. A method according to claim 4 wherein said plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in said compartments.
6. A method according to anyone of claims 1-5 wherein said matrix contains more than one protease.
7. A method according to claim 6 wherein said matrix is in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis.
8. A method according to anyone of claims 1-7 wherein said protease is selected from the group consisting of aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin.
9. A method according to claim 8 wherein the proteases are trypsin, chymotrypsin, proteinase K or papain.
10. A method according to claim 9 wherein the concentrations of each of the proteases along the first axis in each case is from about 50 μg/mL to about 0.5 μg/mL.
11. A method according to claim 10 wherein the concentration for each of the proteases is about 50 μg/mL in one container of a concentration axis; about 25 μg/mL in a second container of the concentration axis; about 5 μg/mL in a third container of the concentration axis; about 2.5 μg/mL in a fourth container of the concentration axis; about 0.5 μg/mL in a fifth container of the concentration axis; about 0 μg/mL in a sixth container of the concentration axis.
12. A method according to any one of claims 1-11 wherein the surface upon which said protease is immobilized has been treated with a blocker of surface interaction.
13. A method according to claim 12 wherein the blocker is selected from the group consisting of BSA and beta-octyl glucoside.
14. A method according to claim 1-13 wherein the apparatus may be prepared and stored prior to use.
15. A method according to any one of claims 1 to 13 wherein the surface to which said protease is immobilized is selected from the group consisting of an organic support of material selected from the group consisting of polyesters, polyamides, polyacrylates, polymethacrylates, polyacrylamides, poly(acrylic acid)m, poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins; cellulose; cellulose derivatives; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and an inorganic support material selected from the group consisting of siliceous and nonsiliceous metal oxides.
16. A method according to any one of claims 1 to 14 wherein said apparatus is a microtitre plate.
17. A method according to claim 16 wherein one of the conditions is time for incubation and is between about 2 to 4 hours.
18. A method according to claim 17 wherein one of the conditions is temperature for a reaction and is room temperature.
19. A method according to anyone of claims 1 to 18 wherein only limited digestion of said protein occurs.
20. A method for determining the boundaries of a proteolytically digested fragment of a protein which comprises the steps: (i) incubating a protein, according to the method of any one of claims 1-19 to yield protein fragments; (ii) isolatation of fragment(s) of interest; (iii) determining the mass of the isolated fragment(s); and (iv) matching the mass of the proteolytic fragment(s) to a protein amino acid sequence of the protein digested.
21. A method according to claim 20 wherein the determination of mass is by a method selected from the group consisting of nanospray time-of-flight mass spectrometry and matrix-assisted time-of-flight mass spectrometry.
22. A method according to claim 21 wherein the protein fragment isolation is carried out by a technique selected from the group consisting of HPLC and SDS PAGE.
23. A method according to claim 20 , 21, or 22 which is automated.
24. An apparatus for degradation of a protein, said apparatus comprising a plurality of compartments, each compartment containing a quantity of a protease immobilized on a surface in each compartment wherein at least two compartments contain different concentrations of said protease.
25. An apparatus according to claim 24 wherein each compartment containing a quantity of said protease contains a concentration of said protease distinct from the concentration of said protease in every other compartment.
26. An apparatus according to claim 25 wherein at least three concentrations of protease are in said compartments.
27. An apparatus according to claim 26 wherein said plurality of compartments forms a matrix in a linear format with at least three increasing concentrations of protease in said compartments.
28. An apparatus according to anyone of claims 24-27 wherein said matrix contains more than one protease.
29. An apparatus according to claim 28 wherein said matrix is in a two-dimensional format wherein: (i) distinct concentrations of each protease are aligned in increasing concentration, along a first axis or concentration axis; and (ii) different proteases are aligned along a second axis that is perpendicular to the first axis.
30. An apparatus according to anyone of claims 24-29 wherein said protease is selected from the group consisting of aminopeptidase M; bromelain; carboxypeptidase A, B and Y; chymopapain; chymotrypsin; clostripain; collagenase; elastase; endoproteinase Arg-C, Glu-C and LysC; Factor Xa; ficin; Gelatinase; kallikrein; metalloendopeptinidase; papain; pepsin; plasmin; plasminogen; peptidase; pronase; proteinase A; proteinase K; subsilisin; thermolysin; thrombin; and trypsin.
31. An apparatus according to claim 30 wherein the proteases are trypsin, chymotrypsin, proteinase K or papain.
32. An apparatus according to claim 31 wherein the concentrations of each of the proteases along the first axis in each case is from about 50 μg/mL to about 0.5 μg/mL.
33. An apparatus according to claim 32 wherein the concentration for each of the proteases is about 50 μg/mL in one container of a concentration axis; about 25 μg/mL in a second container of the concentration axis; about 5 μg/mL in a third container of the concentration axis; about 2.5 μg/mL in a fourth container of the concentration axis; about 0.5 μg/mL in a fifth container of the concentration axis; about 0 μg/mL in a sixth container of the concentration axis.
34. An apparatus according to any one of claims 24-33 wherein the surface upon which said protease is immobilized has been treated with a blocker of surface interaction.
35. An apparatus according to claim 34 wherein the blocker is selected from the group consisting of BSA and beta-octyl glucoside.
36. An apparatus according to any one of claims 24 to 33 wherein the surface to which said protease is immobilized is selected from the group consisting of an organic support of material selected from the group consisting of polyesters, polyamides, polyacrylates, polymethacrylates, polyacrylamides, poly(acrylic acid)m, poly(methacrylic acid); poly(galacturonic acid); poly(aspartic acid); ethylene-maleic anhydride copolymers; polyolefins; cellulose; cellulose derivatives; agarose gels; dextran gels and derivatives thereof, polysaccharides; polypeptides; collagen; and an inorganic support material selected from the group consisting of siliceous and nonsiliceous metal oxides.
37. An apparatus according to claim 24-36 wherein the apparatus may be prepared and stored prior to use.
38. An apparatus according to any one of claims 24 to 37 wherein said apparatus is a microtitre plate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/234,024 US20030104509A1 (en) | 1998-07-15 | 2002-09-03 | Device and method for the determination of protein domain boundaries |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2,243,230 | 1998-07-15 | ||
CA002243230A CA2243230A1 (en) | 1998-07-15 | 1998-07-15 | A device and method for the determination of protein domain boundaries |
US09/720,272 US6451591B1 (en) | 1998-07-15 | 1999-07-15 | Device and method for the determination of protein domain boundaries |
US10/234,024 US20030104509A1 (en) | 1998-07-15 | 2002-09-03 | Device and method for the determination of protein domain boundaries |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/720,272 Continuation US6451591B1 (en) | 1998-07-15 | 1999-07-15 | Device and method for the determination of protein domain boundaries |
PCT/CA1999/000640 Continuation WO2000004384A1 (en) | 1998-07-15 | 1999-07-15 | Device and method for the determination of protein domain boundaries |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030104509A1 true US20030104509A1 (en) | 2003-06-05 |
Family
ID=4162664
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/720,272 Expired - Fee Related US6451591B1 (en) | 1998-07-15 | 1999-07-15 | Device and method for the determination of protein domain boundaries |
US10/234,024 Abandoned US20030104509A1 (en) | 1998-07-15 | 2002-09-03 | Device and method for the determination of protein domain boundaries |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/720,272 Expired - Fee Related US6451591B1 (en) | 1998-07-15 | 1999-07-15 | Device and method for the determination of protein domain boundaries |
Country Status (7)
Country | Link |
---|---|
US (2) | US6451591B1 (en) |
EP (1) | EP1097383B1 (en) |
AT (1) | ATE261127T1 (en) |
AU (1) | AU4597599A (en) |
CA (1) | CA2243230A1 (en) |
DE (1) | DE69915297D1 (en) |
WO (1) | WO2000004384A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019507341A (en) * | 2016-02-04 | 2019-03-14 | オンコバイオロジクス,インコーポレイティド | Method for identification and analysis of amino acid sequence of protein |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2243230A1 (en) * | 1998-07-15 | 2000-01-15 | Aled Edwards | A device and method for the determination of protein domain boundaries |
US20120244594A9 (en) | 1998-09-04 | 2012-09-27 | Cell Signaling Technology, Inc. | Immunoaffinity isolation of modified peptides from complex mixtures |
US7300753B2 (en) * | 1998-09-04 | 2007-11-27 | John Rush | Immunoaffinity isolation of modified peptides from complex mixtures |
US7198896B2 (en) * | 1998-09-04 | 2007-04-03 | Cell Signaling Technology, Inc. | Immunoaffinity isolation of modified peptides from complex mixtures |
US20110111424A1 (en) | 2001-06-21 | 2011-05-12 | Cell Signaling Technology, Inc. | Analysis of ubiquitinated polypeptides |
AU2002325755A1 (en) * | 2001-09-18 | 2003-04-01 | Affinium Pharmaceuticals, Inc. | Methods and apparatuses for purification |
DE10155693A1 (en) * | 2001-11-07 | 2003-05-15 | Florian Schweigert | Method for the detection of apathogenic particles and their pathogenic variants in the organism |
DE10155692A1 (en) * | 2001-11-07 | 2003-05-22 | Florian Schweigert | Procedure for the detection of endogenous and exogenous substances in the organism |
US20050079526A1 (en) * | 2002-02-20 | 2005-04-14 | Affinium Pharmaceuticals, Inc. | Methods and apparatuses for characterizing refolding and aggregation of biological molecules |
AU2003247276A1 (en) * | 2002-02-20 | 2003-09-09 | Affinium Pharmaceuticals, Inc. | Methods and apparatuses for characterizing stability of biological molecules |
US20050181464A1 (en) * | 2002-04-04 | 2005-08-18 | Affinium Pharmaceuticals, Inc. | Novel purified polypeptides from bacteria |
WO2003087834A2 (en) * | 2002-04-08 | 2003-10-23 | Affinium Pharmaceuticals, Inc. | High throughput analysis of recombinant proteins in multi-well plates |
US20040121445A1 (en) * | 2002-07-31 | 2004-06-24 | Fabien Marino | Cell cultures |
US6916455B2 (en) * | 2002-08-14 | 2005-07-12 | The Regents Of The University Of California | Protein crystallography prescreen kit |
WO2006047614A2 (en) * | 2004-10-26 | 2006-05-04 | Invitrogen Corporation | Compositions and methods for analyzing biomolecules using mass spectroscopy |
US20150232540A1 (en) | 2006-07-11 | 2015-08-20 | Cell Signaling Technology, Inc. | Analysis of ubiquitnated polypeptides |
FR2939036B1 (en) | 2008-12-01 | 2010-12-17 | Oreal | METHOD OF ARTIFICIAL COLORING OF THE SKIN USING A MIXTURE OF CAROTENOID AND LIDOPHILE GREEN COLOR NEW MIXTURE OF LIPOPHILIC COLORANTS; COMPOSITION |
US9133450B2 (en) | 2012-01-31 | 2015-09-15 | University Of Calcutta | Thermostable enzymes and methods of making and using the same |
CN104535637B (en) * | 2014-12-11 | 2017-05-10 | 淮海工学院 | Method for verifying macromolecular collagen or gelatin via pepsase enzymolysis |
US10544457B2 (en) * | 2016-06-14 | 2020-01-28 | Pacific Biosciences Of California, Inc. | Methods and compositions for enriching compositions for polymerase enzyme complexes |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3519538A (en) * | 1968-09-05 | 1970-07-07 | Corning Glass Works | Chemically coupled enzymes |
US3556945A (en) * | 1968-02-05 | 1971-01-19 | Corning Glass Works | Enzyme stabilization |
US3666627A (en) * | 1968-10-14 | 1972-05-30 | Corning Glass Works | Method of stabilizing enzymes |
US4146432A (en) * | 1976-05-31 | 1979-03-27 | Sumitomo Chemical Company, Limited | Immobilized proteases |
US5431882A (en) * | 1992-12-04 | 1995-07-11 | Shimadzu Corporation | Apparatus for collecting peptide fragment |
US5856082A (en) * | 1994-08-31 | 1999-01-05 | University Of British Columbia | Devices and methods for characterizing proteins and peptides |
US6221626B1 (en) * | 1998-06-30 | 2001-04-24 | University Of Geneva | Kit for electroblotting polypeptides separated on an electrophoresis gel |
US6451591B1 (en) * | 1998-07-15 | 2002-09-17 | Aled Edwards | Device and method for the determination of protein domain boundaries |
US20030003465A1 (en) * | 1997-09-02 | 2003-01-02 | Daniel Little | Mass spectrometric detection of polypeptides |
US20030175844A1 (en) * | 2002-03-12 | 2003-09-18 | Nadler Timothy K. | Method and apparatus for the identification and quantification of biomolecules |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4403057C1 (en) * | 1994-02-02 | 1994-12-08 | Biotest Pharma Gmbh | Platelet-stabilising factor IX fragments, the preparation thereof and pharmaceutical compositions containing them |
-
1998
- 1998-07-15 CA CA002243230A patent/CA2243230A1/en not_active Abandoned
-
1999
- 1999-07-15 DE DE69915297T patent/DE69915297D1/en not_active Expired - Lifetime
- 1999-07-15 US US09/720,272 patent/US6451591B1/en not_active Expired - Fee Related
- 1999-07-15 AT AT99928974T patent/ATE261127T1/en not_active IP Right Cessation
- 1999-07-15 WO PCT/CA1999/000640 patent/WO2000004384A1/en active IP Right Grant
- 1999-07-15 AU AU45975/99A patent/AU4597599A/en not_active Abandoned
- 1999-07-15 EP EP99928974A patent/EP1097383B1/en not_active Expired - Lifetime
-
2002
- 2002-09-03 US US10/234,024 patent/US20030104509A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3556945A (en) * | 1968-02-05 | 1971-01-19 | Corning Glass Works | Enzyme stabilization |
US3519538A (en) * | 1968-09-05 | 1970-07-07 | Corning Glass Works | Chemically coupled enzymes |
US3666627A (en) * | 1968-10-14 | 1972-05-30 | Corning Glass Works | Method of stabilizing enzymes |
US3802997A (en) * | 1968-10-14 | 1974-04-09 | Corning Glass Works | Method of stabilizing enzymes |
US4146432A (en) * | 1976-05-31 | 1979-03-27 | Sumitomo Chemical Company, Limited | Immobilized proteases |
US5431882A (en) * | 1992-12-04 | 1995-07-11 | Shimadzu Corporation | Apparatus for collecting peptide fragment |
US5856082A (en) * | 1994-08-31 | 1999-01-05 | University Of British Columbia | Devices and methods for characterizing proteins and peptides |
US20030003465A1 (en) * | 1997-09-02 | 2003-01-02 | Daniel Little | Mass spectrometric detection of polypeptides |
US6221626B1 (en) * | 1998-06-30 | 2001-04-24 | University Of Geneva | Kit for electroblotting polypeptides separated on an electrophoresis gel |
US6451591B1 (en) * | 1998-07-15 | 2002-09-17 | Aled Edwards | Device and method for the determination of protein domain boundaries |
US20030175844A1 (en) * | 2002-03-12 | 2003-09-18 | Nadler Timothy K. | Method and apparatus for the identification and quantification of biomolecules |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019507341A (en) * | 2016-02-04 | 2019-03-14 | オンコバイオロジクス,インコーポレイティド | Method for identification and analysis of amino acid sequence of protein |
JP7224914B2 (en) | 2016-02-04 | 2023-02-20 | アウトルック セラピューティクス,インコーポレイティド | Method for identifying and analyzing protein amino acid sequence |
Also Published As
Publication number | Publication date |
---|---|
CA2243230A1 (en) | 2000-01-15 |
EP1097383B1 (en) | 2004-03-03 |
ATE261127T1 (en) | 2004-03-15 |
US6451591B1 (en) | 2002-09-17 |
WO2000004384A1 (en) | 2000-01-27 |
AU4597599A (en) | 2000-02-07 |
EP1097383A1 (en) | 2001-05-09 |
DE69915297D1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6451591B1 (en) | Device and method for the determination of protein domain boundaries | |
Wower et al. | Labeling the peptidyltransferase center of the Escherichia coli ribosome with photoreactive tRNA (Phe) derivatives containing azidoadenosine at the 3'end of the acceptor arm: a model of the tRNA-ribosome complex. | |
US6723510B2 (en) | Methods for separating particulate substrates from solution while minimizing particle loss | |
US20190112632A1 (en) | Method for obtaining peptides | |
JP4719403B2 (en) | Functional protein array | |
EP0871658B1 (en) | Modified avidin and streptavidin molecules and use thereof | |
US20040265810A1 (en) | Methods for isolating and labeling sample molecules | |
AU2002303760A1 (en) | Methods for isolating and labeling sample molecules | |
US20060134774A1 (en) | Detection of protease enzymes | |
Gaskin et al. | Phage display combinatorial libraries of short peptides: ligand selection for protein purification | |
US20210148925A1 (en) | Qualitative analysis of proteins | |
Scopes | Overview of protein purification and characterization | |
Borman | Analytical biotechnology of recombinant products | |
Scopes et al. | Analysis of proteins | |
CA2337353A1 (en) | Device and method for the determination of protein domain boundaries | |
Bayer et al. | [23] Colorimetric enzyme assays for avidin and biotin | |
EP1918713A1 (en) | Analysis of proteolytic processing by mass spectrometry | |
US20030082560A1 (en) | Method of making interactive protein arrays | |
US7291456B2 (en) | Method for determining differences in molecular interactions and for screening a combinatorial library | |
WO2009138250A2 (en) | Identification of ligand recognition domains | |
US20020022231A1 (en) | Method for identifying modulators of DNA structure-specific binding proteins by high-throughput screening | |
Hardin et al. | Cloning, gene expression, and protein purification | |
WO2023157457A1 (en) | Specimen pretreatment method and use thereof | |
SU1606940A1 (en) | Method of qualitative determination of catalitically active molecules of serine proteinases of bacillae | |
US20040209267A1 (en) | Method for identifying interaction between proteins and dna fragments of a genome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AFFINIUM PHARMACEUTICALS, INC., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EDWARDS, ALED;REEL/FRAME:013600/0214 Effective date: 20030402 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |